Product Name:

NebuSelect™ Recombinant Human Histone H2A type 3

Catalog#:

NBL-240516

Description:

NebuSelect™ Recombinant Human Histone H2A type 3(Cat#NBL-240516) is expressed in E.coli without tag.It contains Ser2-Lys130.

Species:

Human

Expression System:

E.coli

Molecular Weight: 

The protein has a predicted MW of 13.99 kDa. The protein migrates to 15-20 kDa based on Bis-Tris PAGE result.

Target Name:

Histone H2A type 3

Target Information:

The family of histone H2A proved that there are a lot of variants associated with cancer development. HIST3H2A is a promising biomarker for predicting prognosis of pancreatic cancer, and it could be a potential therapeutic target. HIST3H2A might regulate the progression of tumor immune in pancreatic cancer through modulating the JAK-STAT pathway. In addition, the role HIST3H2A in pancreatic cancer may be related to DCST1-AS1, HIST1H2B, SLC12A9-AS1.

Amino Acid Sequence: 

Ser2-Lys130

Purity:

＞95%

Formulation:

see COA

Endotoxin:

＜1EU/ug(LAL Method)

Storage: 

4°C for short term. 

-20°C for long term.

To get more information, please contact us freely.